Latest Investment News

Toubani Resources has made significant strides in advancing its Kobada Gold Project, reporting promising drilling results and securing a substantial A$395 million funding package to support project development.

Syrah Resources reported resumed production at its Balama graphite mine and ongoing qualification delays at its Vidalia anode material facility, while US tariffs on Chinese graphite reshape global supply chains.

Microba Life Sciences reports robust Q1 FY26 growth in microbiome diagnostics, introduces workflow-enhancing features, and prepares for key therapeutic deal catalysts by year-end.

AUB Group has received a revised $45 per share acquisition proposal from EQT, prompting the board to grant exclusivity for due diligence. The deal remains non-binding and subject to multiple conditions.

Microba Life Sciences reports a 145% jump in core microbiome test volumes and is on track to achieve regional break-even by FY26, supported by strategic cost cuts and a $14.5 million capital raise.

Hillgrove Resources has accelerated production at its Nugent centre ahead of schedule, driving an 8% rise in copper output and reducing costs. A $28 million capital raise will fund further development and exploration, underpinning growth prospects.

X2M Connect Limited kicks off FY26 with a 25% revenue surge and a significant reduction in net debt, backed by major new contracts across Asia and the Middle East.

AdAlta Limited has completed the final share issuance under its Investment Agreement with the Meurs Group, securing the full $700,000 investment that bolstered its cellular immunotherapy development.

xReality Group (XRG) has reported robust growth driven by its flagship Operator XR training system, securing a landmark $5.7 million contract with the Texas Department of Public Safety and unveiling ambitious plans for new product launches and global expansion.

xReality Group Limited delivered a record-breaking first quarter in FY26, driven by a landmark $5.7 million contract with the Texas Department of Public Safety and a rapidly growing US customer base.

AdAlta Limited has made significant progress in its 'East to West' cellular immunotherapy strategy, advancing licensing negotiations for its first CAR-T product and raising $1.6 million through placements to bolster its financial position.

Sunshine Metals Limited reported a solid cash position of AUD 5.1 million at the end of Q3 2025, supported by a strong financing inflow that offsets ongoing exploration expenditures.